Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2018-10-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Randomized Comparison of Pediatric I-gel, Air-Q With Classic Laryngeal Mask Airway
NCT02757820
I-Gel vs Ambu Laryngeal Mask Airways in Infants and Children Undergoing Surgical Procedures
NCT02938039
Blind Versus Fiberoptic Intubation Through I-GEL
NCT03086941
Volume Versus Pressure Ventilation on Lung Atelectasis
NCT06076395
Re-evaluation of Blind Intubation Through the Air-Q Intubating Laryngeal Airway
NCT03778762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients were compared according to insertion facility, effect on hemodynamic parameters and effective ventilation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
i gel
I gel LMA was inserted for all patients
LMA i gel
insertion of LMA for maintaining airway during anesthesia
Air Q LMA
Air Q LMA was inserted for all patients
LMA i gel
insertion of LMA for maintaining airway during anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LMA i gel
insertion of LMA for maintaining airway during anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* operative time of ≤60 minutes
Exclusion Criteria
* ASA grade ≥II
* current or recently resolved upper respiratory tract infection
* presence of oropharynx or laryngeal pathologies or congenital anomalies
* pathologies inducing reflux or increasing the possibility of aspiration
* allergy to anaesthetic or drugs to be used, renal, cardiac or hepatic diseases, or bronchial asthma
3 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ayman Anis Metry
Assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ASUH1421/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.